Physician profile
Benjamin Raines
NPI 1750797148
$40,063.48
in general payments reported to CMS, 2019-2025
15 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $7,488 · 2021: $407 · 2022: $3,136 · 2023: $199 · 2024: $1,124 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,081 · Travel and Lodging: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,080.63 |
| Travel and Lodging | $876.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,069.90 | 2019-2025 | |
| Smith+Nephew, INC. | $10,940.28 | 2019-2024 | Real Intelligence, Na, Journey II |
| Cgg Medical INC | $3,897.34 | 2020-2022 | |
| Stryker Corporation | $1,467.37 | 2019-2025 | Mako, Insignia, T2 |
| Mid-Atlantic Surgical Systems, LLC | $1,295.68 | 2019-2020 | |
| Maxx Orthopedics, INC. | $733.20 | 2024 | |
| Southern Edge Orthopaedics, INC. | $248.54 | 2025 | |
| Wright Medical Technology, INC. | $102.26 | 2020 | |
| Djo, LLC | $96.30 | 2023-2025 | Cmf |
| Zimmer Biomet Holdings, INC. | $79.64 | 2019 | |
| Depuy Synthes Sales INC. | $38.96 | 2021 | |
| Nevro Corp. | $28.25 | 2024 | Senza |
| Si-Bone, INC. | $26.81 | 2021 | |
| Vericel Corporation | $21.05 | 2025 | Maci |
| Pacira Therapeutics, INC. | $17.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Raines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.